Clinical Trial Update: Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating gonyautoxin 2/3 for acute back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Back Pain
• Pain

Drugs mentioned

• Gonyautoxin 2/3 (gonyautoxin 2/3)

Snippet

Sponsor: Algenis SpA | Conditions: Back Pain, Acute Pain | Phase 1, Phase 2 | Status: COMPLETED